• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病

Behçet's disease.

作者信息

Hirohata Shunsei, Kikuchi Hirotoshi

机构信息

Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.

出版信息

Arthritis Res Ther. 2003;5(3):139-46. doi: 10.1186/ar757. Epub 2003 Apr 2.

DOI:10.1186/ar757
PMID:12723980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC165051/
Abstract

Behçet's disease is characterized by recurrent aphthous stomatitis, uveitis, genital ulcers, and skin lesions. The role of the HLA-B*51 gene has been confirmed in recent years, although its contribution to the overall genetic susceptibility to Behçet's disease was estimated to be only 19%. The production of a variety of cytokines by T cells activated with multiple antigens has been shown to play a pivotal role in the activation of neutrophils. As regards the treatment, anti-tumor necrosis factor alpha therapy has been shown to be effective for mucocutaneous symptoms as well as for sight-threatening panuveitis, although a randomized, controlled trial is required.

摘要

白塞病的特征为复发性口腔溃疡、葡萄膜炎、生殖器溃疡和皮肤病变。近年来,HLA - B*51基因的作用已得到证实,尽管据估计其对白塞病总体遗传易感性的贡献仅为19%。已表明,被多种抗原激活的T细胞产生的多种细胞因子在中性粒细胞的激活中起关键作用。关于治疗,抗肿瘤坏死因子α疗法已被证明对黏膜皮肤症状以及威胁视力的全葡萄膜炎有效,不过仍需要进行随机对照试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/165051/cadd250aa9df/ar757-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/165051/cadd250aa9df/ar757-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ebc/165051/cadd250aa9df/ar757-1.jpg

相似文献

1
Behçet's disease.白塞病
Arthritis Res Ther. 2003;5(3):139-46. doi: 10.1186/ar757. Epub 2003 Apr 2.
2
HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea.韩国HLA - B51及其等位基因类型与白塞病和复发性阿弗他口炎的相关性
Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S31-5.
3
Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.白塞病中肿瘤坏死因子-α基因启动子区域-308和-376位点G→A多态性
Clin Exp Rheumatol. 2003 Jul-Aug;21(4 Suppl 30):S15-8.
4
A strong association between HLA-B*5101 and Behçet's disease in Greek patients.希腊患者中HLA - B*5101与白塞病之间存在强关联。
Tissue Antigens. 1997 Jul;50(1):57-60. doi: 10.1111/j.1399-0039.1997.tb02835.x.
5
Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.以色列阿拉伯人和非阿什肯纳兹犹太人中MIC - A基因及HLA - B51与白塞病的关联。
Ann Rheum Dis. 2002 Feb;61(2):157-60. doi: 10.1136/ard.61.2.157.
6
The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.作为白塞病易感位点的HLA - B51基因内不存在疾病特异性多态性。
Tissue Antigens. 2001 Aug;58(2):77-82. doi: 10.1034/j.1399-0039.2001.580202.x.
7
Uveitis in psoriasis associated with HLA-B51; a link to Behçet's disease?
Br J Dermatol. 1997 Jun;136(6):979-80. doi: 10.1111/j.1365-2133.1997.tb03957.x.
8
HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.土耳其代尼兹利省HLA - B51基因及其表达与白塞病的关联
Mol Biol Rep. 2008 Sep;35(3):345-9. doi: 10.1007/s11033-007-9092-4. Epub 2007 Jun 27.
9
Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.以色列白塞病患者中HLA - B51与B52的紧密关联。
Ann Rheum Dis. 1991 Jun;50(6):351-3. doi: 10.1136/ard.50.6.351.
10
Behçet's disease: an update on the pathogenesis.白塞病:发病机制的最新进展
Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S6-12.

引用本文的文献

1
Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.神经白塞病:临床诊断、生物标志物及免疫发病机制的最新进展
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae123.
2
Visual outcomes and factors predictive of visual loss in Behcet's disease in Sultan Qaboos University Hospital, Oman.阿曼苏丹卡布斯大学医院白塞病的视力预后及视力丧失的预测因素
Oman J Ophthalmol. 2022 Nov 2;15(3):269-273. doi: 10.4103/ojo.ojo_68_22. eCollection 2022 Sep-Dec.
3
Treatment of Connective Tissue Disease-Related Intractable Disease with Biological Therapeutics.

本文引用的文献

1
Cytokine profile in Behçet's disease patients. Relationship with disease activity.白塞病患者的细胞因子谱。与疾病活动的关系。
Scand J Rheumatol. 2002;31(4):205-10. doi: 10.1080/030097402320318387.
2
Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens.从白塞病患者眼部分离出的Vγ9Vδ2 T细胞可识别非肽类异戊烯焦磷酸抗原。
J Neuroimmunol. 2002 Sep;130(1-2):46-54. doi: 10.1016/s0165-5728(02)00208-4.
3
Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.
生物疗法治疗结缔组织病相关难治性疾病
Open Access Rheumatol. 2021 Sep 28;13:293-303. doi: 10.2147/OARRR.S328211. eCollection 2021.
4
Characterization of autologous platelet rich plasma (PRP) and its biological effects in patients with Behçet's Disease.白塞病患者自体富血小板血浆(PRP)的特性及其生物学效应
Regen Ther. 2021 Sep 9;18:339-346. doi: 10.1016/j.reth.2021.08.010. eCollection 2021 Dec.
5
Validity and reliability of a checklist for patients with Behçet's disease based on the International Classification of Functioning, Disability and Health.基于《国际功能、残疾和健康分类》的白塞病患者检查表的有效性和可靠性。
Rheumatol Int. 2022 Jan;42(1):159-165. doi: 10.1007/s00296-021-05001-3. Epub 2021 Sep 22.
6
Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease.日本贝赫切特病国家研究委员会关于神经贝赫切特病的管理建议。
Intern Med. 2020 Oct 1;59(19):2359-2367. doi: 10.2169/internalmedicine.4705-20. Epub 2020 Jun 30.
7
Moesin expression is correlated with its involvement in patients with Behcet's disease.膜突蛋白的表达与其在白塞病患者中的参与情况相关。
Arch Med Sci. 2020 Feb 12;16(4):924-930. doi: 10.5114/aoms.2020.92911. eCollection 2020.
8
Thiol/disulfide homeostasis in patients with ocular-active and ocular-inactive Behçet disease.眼型和非眼型 Behcet 病患者的硫醇/二硫键动态平衡。
Int Ophthalmol. 2020 Oct;40(10):2643-2650. doi: 10.1007/s10792-020-01445-x. Epub 2020 Jun 1.
9
GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease.GWAS 鉴定的 CCR1 和 IL10 基因座有助于贝赫切特病中 M1 巨噬细胞占优势的炎症反应。
Arthritis Res Ther. 2018 Jun 12;20(1):124. doi: 10.1186/s13075-018-1613-0.
10
Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.γδ T 细胞及其在贝赫切特病中的作用。
J Immunol Res. 2015;2015:705831. doi: 10.1155/2015/705831. Epub 2015 Oct 11.
干扰素α-2a治疗白塞病:一项随机安慰剂对照双盲研究。
Arch Dermatol. 2002 Apr;138(4):467-71. doi: 10.1001/archderm.138.4.467.
4
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.白塞病中的血管受累:与血栓形成倾向因素、凝血激活及血栓调节蛋白的关系。
Am J Med. 2002 Jan;112(1):37-43. doi: 10.1016/s0002-9343(01)01048-8.
5
Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.以色列阿拉伯人和非阿什肯纳兹犹太人中MIC - A基因及HLA - B51与白塞病的关联。
Ann Rheum Dis. 2002 Feb;61(2):157-60. doi: 10.1136/ard.61.2.157.
6
Deep vein thrombosis in Behçet's disease.白塞病中的深静脉血栓形成。
Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S48-50.
7
Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23.白塞病一个新的易感基因座与6号染色体p22 - 23区域的连锁图谱。
Arthritis Rheum. 2001 Nov;44(11):2693-6. doi: 10.1002/1529-0131(200111)44:11<2693::aid-art449>3.0.co;2-m.
8
A double-blind trial of colchicine in Behçet's syndrome.秋水仙碱治疗白塞病的双盲试验。
Arthritis Rheum. 2001 Nov;44(11):2686-92. doi: 10.1002/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h.
9
HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease.采用聚合酶链反应-序列特异性寡核苷酸探针技术(PCR-SBT)对HLA-B*51等位基因进行分析,以及HLA-B*5101与日本白塞病患者的强关联。
Tissue Antigens. 2001 Sep;58(3):181-4. doi: 10.1034/j.1399-0039.2001.580306.x.
10
The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.作为白塞病易感位点的HLA - B51基因内不存在疾病特异性多态性。
Tissue Antigens. 2001 Aug;58(2):77-82. doi: 10.1034/j.1399-0039.2001.580202.x.